Bukwang Pharm (003000) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.018x

Based on the latest financial reports, Bukwang Pharm (003000) has a cash flow conversion efficiency ratio of -0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-6.24 Billion ≈ $-4.23 Million USD) by net assets (₩340.83 Billion ≈ $230.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Bukwang Pharm worth for the company's overall valuation and market capitalisation.

Bukwang Pharm - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Bukwang Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bukwang Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bukwang Pharm ranked by their cash flow conversion efficiency. Explore Bukwang Pharm (003000) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Kreditbanken A/S CO:KRE	0.001x
R&B FOOD SUPPLY BK:RBF-R	N/A
Super Energy Tbk PT JK:SURE	0.110x
Bank Ochrony Środowiska SA WAR:BOS	0.047x
Kcc Glass Corp KO:344820	-0.049x
Touchstone International Medical Science Co Ltd SHG:688013	0.045x
Empresas Gasco S.A SN:GASCO	0.055x
Strike Energy Limited F:RJN	-0.013x

Annual Cash Flow Conversion Efficiency for Bukwang Pharm (2007–2024)

The table below shows the annual cash flow conversion efficiency of Bukwang Pharm from 2007 to 2024. View Bukwang Pharm share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩244.15 Billion ≈ $165.45 Million	₩34.36 Billion ≈ $23.29 Million	0.141x	+452.19%
2023-12-31	₩234.26 Billion ≈ $158.76 Million	₩-9.36 Billion ≈ $-6.34 Million	-0.040x	-165.99%
2022-12-31	₩271.85 Billion ≈ $184.23 Million	₩16.46 Billion ≈ $11.16 Million	0.061x	-36.06%
2021-12-31	₩280.06 Billion ≈ $189.79 Million	₩26.52 Billion ≈ $17.98 Million	0.095x	+3451.72%
2020-12-31	₩271.19 Billion ≈ $183.78 Million	₩723.17 Million ≈ $490.08K	0.003x	+103.72%
2019-12-31	₩326.49 Billion ≈ $221.25 Million	₩-23.41 Billion ≈ $-15.86 Million	-0.072x	-534.85%
2018-12-31	₩413.44 Billion ≈ $280.18 Million	₩6.82 Billion ≈ $4.62 Million	0.016x	-59.31%
2017-12-31	₩211.30 Billion ≈ $143.20 Million	₩8.56 Billion ≈ $5.80 Million	0.041x	+212.04%
2016-12-31	₩214.63 Billion ≈ $145.45 Million	₩-7.76 Billion ≈ $-5.26 Million	-0.036x	-179.08%
2015-12-31	₩225.15 Billion ≈ $152.58 Million	₩10.30 Billion ≈ $6.98 Million	0.046x	-65.53%
2014-12-31	₩210.00 Billion ≈ $142.31 Million	₩27.86 Billion ≈ $18.88 Million	0.133x	-26.94%
2013-12-31	₩201.07 Billion ≈ $136.26 Million	₩36.52 Billion ≈ $24.75 Million	0.182x	+11.16%
2007-12-31	₩170.63 Billion ≈ $115.63 Million	₩27.87 Billion ≈ $18.89 Million	0.163x	--

About Bukwang Pharm

KO:003000 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$263.11 Million

₩388.25 Billion KRW

Market Cap Rank

#15535 Global

#528 in Korea

Share Price

₩3935.00

Change (1 day)

+0.13%

52-Week Range

₩3485.00 - ₩9600.00

All Time High

₩36947.85